Modulating the DNA Damage Response to Improve Treatment Response in Cervical Cancer

Cossar, LH, Schache, AG ORCID: 0000-0001-9466-6038, Risk, JM ORCID: 0000-0002-8770-7783, Sacco, JJ, Jones, NJ ORCID: 0000-0003-1801-1456 and Lord, R (2017) Modulating the DNA Damage Response to Improve Treatment Response in Cervical Cancer. Clinical Oncology, 29 (9). pp. 626-634.

Text Cossar et al (2017).docx - Author Accepted Manuscript Download (291kB)

Abstract

Cervical cancer is the 4th most common cause of cancer-related death in women worldwide and new therapeutic approaches are needed to improve clinical outcomes for this group of patients. Current treatment protocols for locally advanced and metastatic disease consist of ionising radiation and chemotherapy. Chemoradiation induces cytotoxic levels of DNA double strand breaks which activates programmed cell death via the DNA Damage Response (DDR). Cervical cancers are unique given an almost exclusive association with Human papillomavirus (HPV) infection; a potent manipulator of the DDR, with the potential to alter tumour sensitivity to DNA damaging agents and influence treatment response. This review highlights the wide range of therapeutic strategies in development which have the potential to modulate DDR and sensitise cervical tumours to DNA damaging agents in the context of HPV oncogenesis.

Item Type:	Article
Uncontrolled Keywords:	Cervical Cancer, HPV, DNA Damage Response
Depositing User:	Symplectic Admin
Date Deposited:	08 Mar 2017 07:34
Last Modified:	19 Jan 2023 07:14
DOI:	10.1016/j.clon.2017.03.002
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3006243